breast cancer

News

T-cells attacking cancer cell illustration of microscopic photos

Novartis scores first approval for PIK3CA breast cancer drug

The FDA has approved Novartis’ breast cancer drug Piqray (alpelisib), making it the first marketed treatment targeting the PIK3CA mutation in this disease.

News

Merck & Co's Keytruda fails in triple negative breast cancer...

Most of the time, Merck & Co’s Keytruda (pembrolizumab) has been a consistent performer across a range of cancers – but it has produced an uncharacteristic failure in tough to treat tri

Views & Analysis

Oncology round-up: AZ and Daiichi score key trial win with b...

AZ and Daiichi Sankyo announced positive top-line results from the pivotal phase 2 DESTINY-Breast01 trial of trastuzumab deruxtecan, an antibody-drug conjugate, in patients with an advanced

News

AZ and Daiichi to file new breast cancer drug after trial su...

In March AstraZeneca asked investors for $3.5 billion to fund a collaboration with Daiichi Sankyo over a new breast cancer drug – and it looks like the project is on track.

News

Genetic test can predict efficacy of chemotherapy in breast ...

Researchers have found that a genetic test can successfully predict whether chemotherapy would be beneficial for patients with the most common type of breast cancer – oestrogen-receptor pos

News

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast c...

The European Commission has approved AstraZeneca and MSD’s Lynparza (olaparib) for the treatment of germline BRCA-mutated HER2-negative advanced breast cancer – making it the first drug app

Novartis scores first approval for PIK3CA breast cancer drug

Merck & Co's Keytruda fails in triple negative breast cancer...

Oncology round-up: AZ and Daiichi score key trial win with b...

AZ and Daiichi to file new breast cancer drug after trial su...

Genetic test can predict efficacy of chemotherapy in breast ...

AZ and MSD’s Lynparza gets EU nod for hard-to-treat breast c...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

breast cancer

Editor's Picks